ZSAN - Zosano Pharma Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue--313
Cost of Revenue---
Gross Profit--313
Operating Expenses
Research Development20,18820,45720,366
Selling General and Administrative8,1828,1766,315
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-28,370-28,633-26,368
Income from Continuing Operations
Total Other Income/Expenses Net7-7-495
Earnings Before Interest and Taxes-28,363-28,640-26,417
Interest Expense7421,1921,564
Income Before Tax-29,105-29,832-27,981
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-29,105-29,832-28,427
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-29,105-29,832-28,427
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-29,105-29,832-28,427